The Venture Codex

Participated · Equity · Feb 2026

Synchrony Medical is a respiratory care technology company focused on improving airway clearance therapy for people with chronic lung conditions. Its flagship product, the FDA-cleared LibAirty™ Airway Clearance System, allows patients to perform daily home treatments that have demonstrated the ability to clear twice as much sputum as conventional therapies while increasing comfort and satisfaction. Commercially launched in late 2025, the device has received strong early adoption from both patients and clinicians. The company plans to use new capital to scale U.S. commercial operations, expand its clinical evidence base, and advance product development. Headquartered in Jersey City, New Jersey, with additional operations in Or Yehuda, Israel, Synchrony collaborates with leading pulmonologists from Sheba Medical Center and has been supported by Edge Medical Ventures’ EdgeLabs and the Israel Innovation Authority. Although revenue and user figures were not disclosed, the oversubscribed nature of the recent round underscores market demand and investor confidence in the company’s growth trajectory.

Participated · Series A · Nov 2025

IBI Ag is an Israeli agri-biotech company pioneering a platform that uses single-domain antibodies (nanobodies) to create highly selective biological insecticides. Adapted from human therapeutics and optimized for agriculture, its products introduce new modes of action that protect high-value crops from both sucking and chewing pests while sparing beneficial species. The firm positions its technology as a lower-ecological-footprint alternative to conventional chemicals, aiming to help farmers boost yields sustainably. With fresh Series A capital, IBI Ag plans to accelerate product development and advance regulatory filings on multiple bio-insecticide candidates. The company also intends to deepen its collaboration with strategic investor Corteva to speed commercialization. Founded by The Trendlines Group alongside Dr. Amir Ayali and Dr. Rony Oren Benaroya, IBI Ag has been supported by the Israel Innovation Authority since inception. Financial details beyond the recent $10 million raise were not disclosed.

Participated · Seed · Dec 2024

Celleste Bio develops cell-cultured cocoa ingredients using a proprietary combination of BioTech, AgTech and computational AI to grow 100% natural cocoa from one or two beans in controlled, year‑round conditions. The company was founded in 2022 and positions its technology as a response to cocoa supply challenges driven by climate change and conventional farming. Celleste intends to pilot and scale production of its cell‑cultured cocoa ingredients and build the infrastructure and technological capabilities needed for commercial readiness. The seed financing will be used to accelerate R&D, expand infrastructure, and advance technological development. The company frames its mission as creating an economically and environmentally sustainable cocoa supply and has support from The Trendlines Group.

Participated · Series B · Jan 2022

Wint equips contractors, developers, owners and facility management teams with solutions leveraging artificial intelligence and IoT to manage water throughout the lifecycle of a building, from construction to operations. Its products focus on leak prevention, detection and water management for commercial facilities, construction sites and industrial manufacturers. The company aims to prevent the hazards, costs, waste and environmental impact associated with water leaks and to cut water waste and related carbon emissions. Led by CEO Alon Geva, Wint serves customers across construction and operations workflows. Wint intends to use its recent funding to support global market expansion and technological innovation. The company raised $35M in a Series C financing. WINT Water Intelligence builds water-management and leak-prevention software and hardware for construction, commercial, and industrial applications. Its platform helps owners, contractors, facility managers, and insurers detect and prevent leaks, reduce consumption, and avoid costly water damage. The company says customers can reduce water consumption by 20–25% and cut operational expenses and environmental footprints. WINT frames its solution against broader impacts—citing that 13% of U.S. electricity consumption is related to water distribution and treatment and that water damage drives over $13 billion in annual insurance payouts. The company plans market expansion and continued innovation to accelerate adoption across the built environment. WINT recently completed a $15 million Series B to fund that growth and go-to-market scaling.

Participated · Seed · Oct 2021

RepAir Carbon develops a battery- and fuel-cell‑inspired direct air capture system that uses electricity to drive a reversible chemical reaction to remove CO2. Its reactor uses two electrodes separated by a membrane; a nickel‑based electrode with hydroxide attracts CO2, converting it into carbonate and bicarbonate ions that migrate to the opposite electrode and are released as CO2 for capture. The company says this electrically driven, reversible process allows regeneration while operating, reducing downtime compared with solvent‑heating approaches. RepAir claims its approach could lower capture costs to about $70–$80 per metric ton versus roughly $600 per ton estimated for other approaches. The technology is intended for both atmospheric capture and exhaust-stream capture from power plants and similar sources. RepAir is engaging with developers to integrate its system with gas turbines to cut emissions from data centers. RepAir Carbon Capture develops a modular direct air capture (DAC) system that captures carbon dioxide from ambient air using renewable electricity. Led by CEO Amir Shiner and founded in 2020, the company's design uses multiple cell stacks to enable modularity, scalability, and affordability. RepAir's technology is said to use roughly 70% less energy than conventional DAC systems. The system is engineered for gigaton-scale CO2 separation while targeting lower energy and capital intensity. The company plans to use recent funding to expand operations and continue development efforts. RepAir Carbon has adapted ideas from fuel cell technology to build a modular direct air capture (DAC) “cell” that uses an electrical current and a selective membrane to separate CO2 from ambient air. The company says its approach can consume up to three times less energy per tonne of CO2 captured and avoids the high temperatures and pressure differentials required by many existing DAC systems. RepAir emphasizes a lower CapEx, electrochemical, Lego‑like modular design intended to enable deployment at scale and placement next to intermittent renewables such as wind farms. The startup is focused on advancing and optimizing a TRL3 prototype as its next technical milestone. RepAir aims to develop the platform toward gigaton-scale capture and storage of greenhouse gases. The team includes co-founder and CEO Amir Shiner, co-founder and chairman Yehuda Borenstein, CTO Ben Achrai, PhD, and board member Yushan Yan, PhD; the company is Israel-based and currently funded by a recent seed round.